You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Immunomodulatory drug

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Multiple Myeloma Trial (Elranatamab (PF-06863135))

Temporarily not available
  • Multiple Myeloma
  • Elranatamab (PF-06863135)
  • (no location specified)
Jul 15, 2022

Physiological Effects of Drugs Trial in Rio De Janeiro (Dexmedetomidine Hydrochloride)

Recruiting
  • Physiological Effects of Drugs
  • Dexmedetomidine Hydrochloride
  • Rio De Janeiro, Brazil
    University Hospital Gaffree and Guinle
Aug 3, 2022

Multiple Myeloma Trial in West Hollywood, Cary (Selinexor, Placebo (for selinexor), carfilzomib)

Withdrawn
  • Multiple Myeloma
  • West Hollywood, California
  • +1 more
Jan 24, 2023

Alzheimer Trial in Paris (Proleukin, Placebo)

Not yet recruiting
  • Alzheimer Disease
  • Paris, France
    GHU Saint Anne
Jul 18, 2022

Recurrent Plasma Cell Myeloma, Refractory Plasma Cell Myeloma Trial in Rochester (Carfilzomib, Dexamethasone, Pomalidomide)

Recruiting
  • Recurrent Plasma Cell Myeloma
  • Refractory Plasma Cell Myeloma
  • Rochester, Minnesota
    Mayo Clinic in Rochester
Jun 3, 2022

Plasma Cell Myeloma, Recurrent Plasma Cell Myeloma, Refractory Plasma Cell Myeloma Trial in Phoenix, Jacksonville, Rochester

Recruiting
  • Plasma Cell Myeloma
  • +3 more
  • Bone Marrow Biopsy
  • +3 more
  • Phoenix, Arizona
  • +2 more
Jan 18, 2023

Elranatamab, Myeloma, Multiple Myeloma Trial in China (Elranatamab)

Recruiting
  • Elranatamab
  • +10 more
  • Fuzhou, Fujian, China
  • +18 more
Jan 18, 2023

HIV Infection Trial in United States (Placebo, Maraviroc)

Completed
Has Results
  • HIV Infection
  • San Francisco, California
  • +3 more
Jul 23, 2020

Multiple Myeloma Trial in Beijing, Jiang Su Province (Belantamab mafodotin)

Completed
  • Multiple Myeloma
  • Belantamab mafodotin
  • Beijing, China
  • +2 more
Feb 8, 2022

the Immunomodulatory Effect Trial in Assiut (Vitamin D, Steroid Drug)

Completed
  • the Immunomodulatory Effect
  • Vitamin D
  • Steroid Drug
  • Assiut, Assuit, Egypt
    Manal Hassanien
Jun 20, 2021

Multiple Myeloma Trial in United States (Atezolizumab (MPDL3280A), an engineered anti-PD-L1 antibody, Daratumumab, Lenalidomide)

Completed
  • Multiple Myeloma
  • Atezolizumab (MPDL3280A), an engineered anti-PD-L1 antibody
  • +4 more
  • Birmingham, Alabama
  • +30 more
Mar 31, 2021

Multiple Myeloma Trial in Canada, United States (PF-06863135 monotherapy IV or SC, PF-06863135 + dexamethasone, PF-06863135 +

Active, not recruiting
  • Multiple Myeloma
  • PF-06863135 monotherapy IV or SC
  • +3 more
  • Encinitas, California
  • +37 more
Jul 7, 2022

Glioblastoma, Squamous Cell Carcinoma, Hodgkin Lymphoma Trial (AVM0703, Hydrocortisone, Proton pump inhibitor)

Available
  • Glioblastoma
  • +13 more
  • (no location specified)
Jul 26, 2023

Real-life Current Standards of Care in Relapsed and/or

Completed
  • Multiple Myeloma
  • No intervention
  • Tucson, Arizona
  • +85 more
Dec 20, 2022

Rheumatic Diseases Trial in Ciudad Autónoma de Buenos Aires (Immunosuppressive Agents)

Completed
  • Rheumatic Diseases
  • Immunosuppressive Agents
  • Ciudad Autónoma de Buenos Aires, Caba, Argentina
    Sociedad Argentina de Reumatología
Jan 30, 2023

Viremia, Bacteremia, Acute Rejection of Renal Transplant Trial (IVIG)

Not yet recruiting
  • Viremia
  • +2 more
  • (no location specified)
Apr 3, 2023

Multiple Myeloma Trial in Worldwide (Elranatamab (PF-06863135))

Active, not recruiting
  • Multiple Myeloma
  • Elranatamab (PF-06863135)
  • Beverly Hills, California
  • +75 more
Oct 4, 2022

NSCLC Trial in Iowa City (Durvalumab, Pharmacological ascorbate, Surgery (SOC))

Not yet recruiting
  • Non-small Cell Lung Cancer
  • Iowa City, Iowa
    University of Iowa
Oct 10, 2023

Triple-Negative Breast Cancer Trial in Shanghai (Famitinib, Camrelizumab, nab-Palitaxel/Capecitabine/Eribulin

Not yet recruiting
  • Triple-Negative Breast Cancer
  • Shanghai, Shanghai, China
    Breast cancer institute of Fudan University Cancer Hospital
Feb 27, 2023

Relapsed/ Refractory Multiple Myeloma Trial in Worldwide (Talquetamab, Belantamab Mafodotin)

Not yet recruiting
  • Relapsed/ Refractory Multiple Myeloma
  • Fayetteville, Arkansas
  • +75 more
Aug 11, 2022

Chronic Heart Failure Patients Trial (Eprolidone)

Not yet recruiting
  • Chronic Heart Failure Patients
  • (no location specified)
Jun 28, 2023

Membranous Nephropathy Trial in Nice (Peginterferon Alfa-2A 180 MCG/ML Injectable Solution)

Not yet recruiting
  • Membranous Nephropathy
  • Peginterferon Alfa-2A 180 MCG/ML Injectable Solution
  • Nice, France
    CHU de NICE
Jul 4, 2023

Mental Disorder Trial in France (immunomodulatory treatment by rituximab)

Not yet recruiting
  • Mental Disorder
  • immunomodulatory treatment by rituximab
  • Bordeaux, France
  • +8 more
Jul 7, 2023

Triple-Negative Breast Cancer Trial in Shanghai (Camrelizumab plus Famitinib with/without nab-Palitaxel)

Not yet recruiting
  • Triple-Negative Breast Cancer
  • Camrelizumab plus Famitinib with/without nab-Palitaxel
  • Shanghai, Shanghai, China
    Fudan University Shanghai Cancer Center Shanghai, China, 200032
Jan 2, 2023

Rheumatoid Arthritis, Psoriatic Arthritis, Spondylarthritis Trial in Birmingham, Omaha (Upadacitinib, Abatacept, Secukinumab)

Recruiting
  • Rheumatoid Arthritis
  • +2 more
  • Birmingham, Alabama
  • +7 more
Sep 19, 2022